Research in the Wildschutte lab focuses on improving health through novel drug discovery and biocontrol applications. We utilize a bacterial population-level approach, molecular techniques, and genome analyses to identify and study environmental isolates that inhibit multi-drug resistant bacterial and fungal pathogens.
M.S. and Ph.D. positions are available.
RECENT NEWS:
Congratulations to Michael Fyfe for successfully defending his MS thesis! Now, onto becoming a Ph.D. candidate.
People say glacier ice-melt is safe to drink, but our study suggests differently.
Our recent publication highlights how student crowdsourcing research contributes to biotech collaborations.
A news report on our opioid crisis research: soil-based bacteria can kill a deadly, drug-resistant fungus found in used needles.
A collaboration with our Introduction to Microbiology students and Betco, a biotech company.
Antimicrobial infections are now a leading cause of death worldwide.
In our 2020 manuscript, students perform bioinformatics research in a microbiology course. This strategy can be a solution for in-person and online teaching which exposes students to authetic drug discovery research. Check it out: Expanding Tiny Earth to genomics: a bioinformatic approach for an undergraduate class to characterize antagonistic strains.